Spitz Nevus in Children: A Pink Dome‑Shaped Mole

Spitz nevus is a benign melanocytic lesion that commonly presents as a pink, dome‑shaped papule or nodule in children and adolescents. Also known as benign juvenile melanoma, this nevus can be alarming due to its rapid growth and striking histological features. Understanding spitz nevus pathology outlines is essential for accurate differentiation from malignant melanoma. In this article, we delve into the clinical presentation, histopathology, diagnostic modalities, and management of this intriguing entity.

First described by Sophie Spitz in 1948, spitz nevus typically appears on the face, trunk, or extremities. It often arises in the first two decades of life, though adult cases occur. The classic spitz nevus mole is a solitary, firm, pink to red papule or nodule, usually less than 1 cm in diameter. Its surface may be smooth, papillomatous, or crusted. Rapid growth over weeks to months is common, leading to concern for melanoma.

Epidemiology and Etiology

Spitz nevus accounts for approximately 1% of all melanocytic nevi in children. The incidence peaks between ages 5 and 12, with no clear gender predilection. While the exact etiology remains unknown, ultraviolet radiation exposure and genetic predisposition are thought to play a role. Recent studies have identified HRAS mutations in a subset of spitz nevi, distinguishing them from common nevi and melanoma. The lesion is considered a benign proliferation of melanocytes with limited growth potential. Importantly, spitz nevus pathology outlines show that these lesions exhibit maturation with depth, a key feature that helps differentiate them from melanoma.

Clinical Variants and Dermoscopic Findings

The typical spitz nevus mole is pink, but several variants exist. The pigmented spitz nevus (Reed nevus) appears as a dark brown or black papule, often with a starburst pattern on dermoscopy. The desmoplastic spitz nevus is a firm, hypopigmented nodule that may mimic a dermatofibroma. Atypical spitz tumors (AST) are borderline lesions with concerning histologic features but uncertain malignant potential. Dermoscopic evaluation of spitz nevus often reveals a symmetric, regularly arranged vascular pattern with dotted or comma vessels. In pigmented variants, a reticular depigmentation and peripheral globules are common. These dermoscopic clues, when combined with clinical history, can guide the need for biopsy.

The rapid growth of spitz nevus can be unsettling for parents and clinicians. Unlike common nevi that evolve slowly, spitz nevus may double in size over a few months. This growth phase is typically followed by stabilization. Ulceration or bleeding is unusual and should prompt further investigation. Despite its benign nature, the clinical resemblance to melanoma means that biopsy is often performed to confirm the diagnosis.

Histopathology: The Gold Standard

Histologic examination remains the cornerstone for diagnosing spitz nevus. Under the microscope, spitz nevus pathology outlines a well‑circumscribed, symmetric proliferation of epithelioid and spindle‑shaped melanocytes. The cells are arranged in nests at the dermo‑epidermal junction and within the dermis, with clear maturation (smaller cells) deeper in the lesion. Key features include large epithelioid cells with abundant pink cytoplasm, vesicular nuclei, and prominent nucleoli. Kamino bodies—eosinophilic, PAS‑positive globules at the junction—are present in up to 80% of cases. Mitotic figures are often seen in the superficial portion but are rare in the deep dermis.

Immunohistochemistry plays a supportive role. Melanocytic markers (S100, SOX10, Melan‑A) are positive. HMB‑45 (gp100) expression is typically strong in the epidermal component and fades with depth, a pattern referred to as “maturation of HMB‑45.” This is a helpful feature in spitz nevus pathology outlines to differentiate from melanoma, where HMB‑45 often remains strong throughout. In addition, the proliferation index (Ki67) is low in spitz nevus, contrasting with melanoma. Molecular studies such as FISH and CGH can detect chromosomal copy number changes; benign spitz nevi usually lack the multiple gains and losses seen in melanoma.

Differential Diagnosis

The main differential diagnosis is spitzoid melanoma, a rare but aggressive variant of melanoma that histologically resembles spitz nevus. Distinguishing features include asymmetry, lack of maturation, high mitotic rate (especially deep), ulceration, and pagetoid spread. Other differentials include hemangioma (which shows vascular differentiation), pyogenic granuloma (lacks melanocytes), and common melanocytic nevi (which have smaller cells and less cellular atypia). Clinical correlation is essential: spitz nevus is far more common in children, while melanoma is exceedingly rare. However, in adults, any spitzoid lesion should be treated with caution.

Another challenging entity is the atypical spitz tumor (AST). These lesions exhibit some concerning features but do not meet full criteria for melanoma. ASTs have an uncertain malignant potential, and management is controversial. Referral to a dermatopathologist with expertise in pigmented lesions is recommended. Molecular diagnostics can provide additional prognostic information; for example, presence of TERT promoter mutations or homozygous CDKN2A deletions may indicate higher risk.

Management and Treatment

For typical spitz nevus in children, conservative management is appropriate. Complete excision with clear margins is both diagnostic and curative. In cosmetically sensitive areas, a shave biopsy can be considered, but re‑excision may be needed if margins are involved. Observation is an option for classic lesions in very young children, provided they are monitored for any change. The risk of malignant transformation is extremely low, and routine surveillance imaging is not necessary.

For atypical spitz tumors, wide local excision with 1‑2 cm margins is often recommended. Sentinel lymph node biopsy (SLNB) may be considered in older children and adults, but its prognostic value is debated. Most patients with AST have an excellent prognosis, even when SLNB is positive. Clinical trials are ongoing to better stratify risk. It is important to counsel families about the benign nature of spitz nevus and to avoid overtreatment.

• Spitz nevus is most common in children and adolescents.
• The classic spitz nevus mole is a pink, dome‑shaped papule.
• Its pathology outlines include Kamino bodies and maturation.
• Molecular testing aids in ambiguous cases.
• Conservative excision is standard for typical lesions.

Prognosis and Follow‑Up

The prognosis for spitz nevus is excellent. Recurrence is rare after complete excision. There is no evidence that this nevus transforms into melanoma, though some studies suggest that atypical spitz tumors may have a slightly elevated risk. Long‑term follow‑up is not required for typical cases. Patients and parents should be educated to monitor for any change in the lesion or development of new lesions. Sun protection is recommended to reduce the risk of other skin cancers.

In summary, spitz nevus is a benign melanocytic nevus with characteristic clinical and histologic features. Familiarity with its pathology outlines is crucial for accurate diagnosis. The typical mole is a recognizable pink dome‑shaped lesion that can be managed conservatively. By understanding its benign nature and low malignant potential, clinicians can avoid unnecessary aggressive treatment and reassure patients and families.

Keywords: spitz nevus, spitz nevus pathology outlines, spitz nevus mole.